Stockscreener 앱 받기
1.64
0.61%
0.01
시간 외 거래:
1.63
-0.01
-0.61%
전일 마감가:
$1.63
열려 있는:
$1.63
하루 거래량:
6.86M
Relative Volume:
1.23
시가총액:
$197.03M
수익:
-
순이익/손실:
$-225.14M
주가수익비율:
-0.8367
EPS:
-1.96
순현금흐름:
$-192.27M
1주 성능:
+34.43%
1개월 성능:
+41.38%
6개월 성능:
+230.11%
1년 성능:
+80.92%
1일 변동 폭
$1.60
$1.785
1주일 범위
$1.145
$1.785
52주 변동 폭
$0.3546
$2.74
Invivyd Inc Stock (IVVD) Company Profile
명칭
Invivyd Inc
전화
(781) 819-0080
주소
1601 TRAPELO ROAD, WALTHAM
IVVD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.64 | 349.49M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-03-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 개시 | H.C. Wainwright | Buy |
Invivyd Inc 주식(IVVD)의 최신 뉴스
Are Investors Undervaluing Invivyd, Inc. (NASDAQ:IVVD) By 31%? - 富途牛牛
Invivyd (IVVD) Is Up 26.8% After FDA Clears Phase 3 Trials for COVID Antibody Candidate - simplywall.st
Invivyd (IVVD): Assessing Valuation After FDA Clears Phase 3 COVID-19 Antibody Trial - Yahoo Finance
D. Boral Capital Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
Invivyd receives FDA clearance for COVID antibody prevention trials By Investing.com - Investing.com Nigeria
D. Boral Capital Increases Invivyd (NASDAQ:IVVD) Price Target to $2.00 - MarketBeat
Invivyd, Inc. Announces U.S. Food and Drug Administration Clearance of Investigational New Drug Application and Provide Feedback to Advance the Company's Revolation Clinical Program - MarketScreener
New Haven biotech advances vaccine-alternative to prevent COVID - Hartford Business Journal
Invivyd stock soars after FDA clears IND for COVID antibody candidate - Investing.com
Cantor Fitzgerald Initiates Invivyd at Overweight With $10 Price Target - MarketScreener
This Commerce Bancshares Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Invivyd Shares Climb After FDA Advances Its Covid-Preventing Drug - MarketScreener
Invivyd, Inc. (NASDAQ:IVVD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Invivyd (NASDAQ:IVVD) Now Covered by Cantor Fitzgerald - MarketBeat
Invivyd announces IND clearance, alignment with FDA on VYD2311 program - TipRanks
Invivyd’s VYD2311 Receives FDA Clearance for Trials - TipRanks
Invivyd receives FDA clearance for COVID antibody prevention trials - Investing.com
Invivyd gets FDA nod to start key trial of COVID-blocking antibody VYD2311 - MarketScreener
Invivyd Announces Upcoming Phase 3 Clinical Trials for VYD2311, a Novel COVID Prevention Therapy - Quiver Quantitative
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - Yahoo Finance
How supply chain issues affect Invivyd Inc. stockWeekly Gains Summary & High Conviction Trade Alerts - newser.com
Is Invivyd Inc. stock in correction or buying zone2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
What to do if you’re stuck in Invivyd Inc.Exit Point & Fast Exit and Entry Trade Guides - newser.com
Earnings visualization tools for Invivyd Inc.July 2025 Intraday Action & Daily Profit Focused Screening - newser.com
How Invivyd Inc. stock performs in interest rate cyclesGap Down & Weekly Return Optimization Plans - newser.com
Why retail investors pile into Invivyd Inc. stockJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
How moving averages guide Invivyd Inc. tradingPortfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
Multi asset correlation models including Invivyd Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Is Invivyd Inc. stock safe for conservative investorsWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Applying chart zones and confluence areas to Invivyd Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Can you recover from losses in Invivyd Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Is Invivyd Inc a good long term investmentVolume Analysis Techniques & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Invivyd Inc stockStock Rotation Strategies & Small Budget Trading Ideas - earlytimes.in
Invivyd Appoints New Director Amid Nasdaq Compliance - The Globe and Mail
Invivyd appoints Wave Life Sciences CEO to board of directors By Investing.com - Investing.com Australia
Invivyd appoints Wave Life Sciences CEO to board of directors - Investing.com
Invivyd Appoints Paul B. Bolno, M.D. To Its Board Of Directors - TradingView
Invivyd, Inc. Appoints Dr. Paul B. Bolno to Board of Directors - Quiver Quantitative
Invivyd appoints Wave Life Sciences CEO Paul Bolno to board - TipRanks
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors - The Manila Times
How to contact the Daily Bulletin - FinancialContent
Invivyd Inc (IVVD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
4.71%
자본화:
|
볼륨(24시간):